Physician profile
Merrill S Wise
NPI 1922089192
$7,430.55
in general payments reported to CMS, 2019-2025
29 companies · $610 in 2025
The $610 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,646 · 2020: $179 · 2021: $571 · 2022: $1,395 · 2023: $1,133 · 2024: $897 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,989 · Consulting Fee: $480 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,988.89 |
| Consulting Fee | $480.00 |
| Education | $169.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $2,711.73 | 2019-2025 | |
| Harmony Biosciences LLC | $1,177.99 | 2021-2025 | Wakix |
| United Therapeutics Corporation | $557.14 | 2019-2025 | Tyvaso, Orenitram, Tyvaso |
| Astrazeneca Pharmaceuticals LP | $498.46 | 2021-2025 | Fasenra, Tezspire, Airsupra |
| Zoll Medical Corporation | $480.00 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $393.84 | 2020-2025 | Ofev, Jascayd |
| Genzyme Corporation | $337.05 | 2021-2024 | |
| La Jolla Pharmaceutical Company | $207.16 | 2022 | |
| Philips North America LLC | $163.36 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $130.86 | 2022-2024 | Zerbaxa, Recarbrio, Winrevair |
| Grifols USA, LLC | $122.30 | 2022-2024 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $70.78 | 2023-2025 | Glassia |
| Regeneron Healthcare Solutions, INC. | $63.30 | 2023-2024 | Dupixent |
| Fisher & Paykel Healthcare INC | $52.32 | 2020-2025 | Fisher & Paykel Healthcare |
| Genentech USA, INC. | $50.85 | 2022-2025 | Xolair |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $48.58 | 2025 | Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $46.16 | 2023 | |
| Baxter Healthcare | $43.83 | 2023-2024 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
| Zoll Respicardia, INC. | $43.50 | 2022-2024 | Remede System |
| Axsome Therapeutics, INC. | $38.44 | 2024 | Sunosi |
| Arbor Pharmaceuticals, INC. | $37.60 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $28.89 | 2025 | Lumryz |
| Gilead Sciences, INC. | $24.84 | 2021 | |
| Pulmonx Corporation | $21.60 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Alexion Pharmaceuticals, INC. | $21.51 | 2022 | |
| Mallinckrodt Hospital Products INC. | $16.48 | 2022 | |
| Viatris Specialty LLC | $16.37 | 2025 | Yupelri |
| Sunovion Pharmaceuticals INC. | $13.67 | 2020 | |
| Vapotherm INC | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Merrill Wise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.